Pinmoore Animal Laboratory Services Ltd 05726828 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is Veterinary activities. Digita Accounts Production Advanced 6.30.9574.0 true true false 05726828 2024-01-01 2024-12-31 05726828 2024-12-31 05726828 bus:OrdinaryShareClass1 2024-12-31 05726828 core:CurrentFinancialInstruments 2024-12-31 05726828 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 05726828 core:Non-currentFinancialInstruments 2024-12-31 05726828 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 05726828 core:FurnitureFittings 2024-12-31 05726828 core:LandBuildings core:ShortLeaseholdAssets 2024-12-31 05726828 core:OfficeEquipment 2024-12-31 05726828 core:PlantMachinery 2024-12-31 05726828 bus:SmallEntities 2024-01-01 2024-12-31 05726828 bus:Audited 2024-01-01 2024-12-31 05726828 bus:FilletedAccounts 2024-01-01 2024-12-31 05726828 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 05726828 bus:RegisteredOffice 2024-01-01 2024-12-31 05726828 bus:Director5 2024-01-01 2024-12-31 05726828 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 05726828 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05726828 core:ComputerEquipment 2024-01-01 2024-12-31 05726828 core:FurnitureFittings 2024-01-01 2024-12-31 05726828 core:LandBuildings core:ShortLeaseholdAssets 2024-01-01 2024-12-31 05726828 core:LeaseholdImprovements 2024-01-01 2024-12-31 05726828 core:OfficeEquipment 2024-01-01 2024-12-31 05726828 core:PlantMachinery 2024-01-01 2024-12-31 05726828 4 2024-01-01 2024-12-31 05726828 1 2024-01-01 2024-12-31 05726828 countries:EnglandWales 2024-01-01 2024-12-31 05726828 2023-12-31 05726828 core:FurnitureFittings 2023-12-31 05726828 core:LandBuildings core:ShortLeaseholdAssets 2023-12-31 05726828 core:OfficeEquipment 2023-12-31 05726828 core:PlantMachinery 2023-12-31 05726828 2023-01-01 2023-12-31 05726828 2023-12-31 05726828 bus:OrdinaryShareClass1 2023-12-31 05726828 core:CurrentFinancialInstruments 2023-12-31 05726828 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 05726828 core:Non-currentFinancialInstruments 2023-12-31 05726828 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 05726828 core:FurnitureFittings 2023-12-31 05726828 core:LandBuildings core:ShortLeaseholdAssets 2023-12-31 05726828 core:OfficeEquipment 2023-12-31 05726828 core:PlantMachinery 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 05726828

Pinmoore Animal Laboratory Services Ltd

Filleted Financial Statements

for the Year Ended 31 December 2024

 

Pinmoore Animal Laboratory Services Ltd

Contents

Balance Sheet

1

Notes to the Financial Statements

2 to 8

 

Pinmoore Animal Laboratory Services Ltd

(Registration number: 05726828)
Balance Sheet as at 31 December 2024

Note

31 December
2024
£

31 December
2023
£

Fixed assets

 

Tangible assets

4

25,925

41,742

Current assets

 

Stocks

5

38,816

13,499

Debtors

6

308,518

257,958

Cash at bank and in hand

 

68,888

17,843

 

416,222

289,300

Creditors: Amounts falling due within one year

7

(422,158)

(635,739)

Net current liabilities

 

(5,936)

(346,439)

Total assets less current liabilities

 

19,989

(304,697)

Creditors: Amounts falling due after more than one year

7

(4,409)

(46,393)

Net assets/(liabilities)

 

15,580

(351,090)

Capital and reserves

 

Called up share capital

11

500,100

100

Retained earnings

(484,520)

(351,190)

Shareholders' funds/(deficit)

 

15,580

(351,090)

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 30 May 2025
 

.........................................
A D Nelson
Director

   
     
 

Pinmoore Animal Laboratory Services Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit G1 Valiant Way
i54 Business Park
Wolverhampton
Staffordshire
WV9 5GB
United Kingdom

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

In August 2024, Pinmoore joined the Eurofins network when its ultimate holding company DNACO Limited became a wholly owned subsidiary of Eurofins Scientific SE.

The new leadership will assist management to grow the business with new marketing initiatives and cost reduction programs. As a result EBITDA is expected to increase in 2025.

It is group policy to provide internal funding for companies and the Eurofins NSC Treasury monitor the cash for this company on a weekly basis.

In view of the above the directors believe that it is appropriate to prepare the financial statements on a going concern basis.

Audit report

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 2 June 2025 was Caroline Webster FCA, who signed for and on behalf of UHY Ross Brooke.

Reclassification of comparative amounts

Following acquisition of the company's ultimate parent by Eurofins Forensics Lux, the company has brought its allocation of costs in line with the Eurofins group and the comparatives have been adjusted accordingly. The result is to include additional costs within cost of sales as the group believes these costs are more appropriately shown as directly relating to sales. This adjustment amounted to an increase in cost of sales of £90,438 and a corresponding decrease in administrative expenses.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

 

Pinmoore Animal Laboratory Services Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax payable.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in
the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be
recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the
reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

20% straight line

Computer equipment

33.3% straight line

Fixtures and fittings

20% straight line

Leasehold improvements

10% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

 

Pinmoore Animal Laboratory Services Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in
the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

Up to November 2024 the payroll was recharged by the parent company Orchid Cellmark Limited. The average number of persons recharged during the year was 16 (2023 - 16). Recharges totalling £420,534 (2023: £441,891) were made in the year.

From December 2024, the average number of persons employed by the company was 16 (2023 - 0).

 

Pinmoore Animal Laboratory Services Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

4

Tangible assets

Short leasehold land and buildings
£

Fixtures and fittings
£

Computer equipment
£

Office equipment
£

Total
£

Cost or valuation

At 1 January 2024

-

67,770

4,978

18,927

91,675

Disposals

-

(5,144)

(2,372)

(2,572)

(10,088)

Transfers

61,000

(60,796)

3,927

(4,131)

-

At 31 December 2024

61,000

1,830

6,533

12,224

81,587

Depreciation

At 1 January 2024

-

32,799

4,566

12,568

49,933

Charge for the year

2,033

2,331

69

424

4,857

Eliminated on disposal

-

(3,369)

(2,344)

(1,834)

(7,547)

Fair value adjustments

3,139

464

1,172

3,644

8,419

Transfers

29,903

(30,395)

3,070

(2,578)

-

At 31 December 2024

35,075

1,830

6,533

12,224

55,662

Carrying amount

At 31 December 2024

25,925

-

-

-

25,925

At 31 December 2023

-

34,971

412

6,359

41,742

 

Pinmoore Animal Laboratory Services Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

The fixed asset categories and depreciation were aligned to Eurofins policy on acquisition and resulted in an additional depreciation charge of £8,419 as a fair value adjustment.

5

Stocks

31 December
2024
£

31 December
2023
£

Raw materials and consumables

38,816

13,499

6

Debtors

Current

31 December
2024
£

31 December
2023
£

Trade debtors

187,280

152,223

Prepayments

11,748

4,000

Other debtors

109,490

101,735

 

308,518

257,958

 

Pinmoore Animal Laboratory Services Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

7

Creditors

Creditors: amounts falling due within one year

Note

31 December
2024
£

31 December
2023
£

Due within one year

 

Loans and borrowings

8

44,214

51,067

Trade creditors

 

79,548

111,276

Amounts owed to related parties

202,806

313,253

Taxation and social security

 

48,338

60,884

Other creditors

 

47,252

99,259

 

422,158

635,739

Creditors: amounts falling due after more than one year

Note

31 December
2024
£

31 December
2023
£

Due after one year

 

Loans and borrowings

8

4,409

46,393

8

Loans and borrowings

Current loans and borrowings

31 December
2024
£

31 December
2023
£

Bank borrowings

41,419

48,019

Other borrowings

2,795

3,048

44,214

51,067

 

Pinmoore Animal Laboratory Services Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

Non-current loans and borrowings

31 December
2024
£

31 December
2023
£

Bank borrowings

4,409

45,823

Other borrowings

-

570

4,409

46,393

9

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £148,833 ( 2023 - £186,833). Financial commitments relate to non-cancellable operating lease commitments for property.

10

Parent and ultimate parent undertaking

The company's immediate parent is Orchid Cellmark Ltd, incorporated in England and Wales.

 The ultimate parent is Eurofins Scientific SE, incorporated in Luxembourg.

  These financial statements are available upon request from the ultimate parent company's website.

 

11

Share capital

Allotted, called up and fully paid shares

31 December
2024

31 December
2023

No.

£

No.

£

Ordinary shares of £1 each

500,100

500,100

100

100

       

On 6 December 2024, a loan due to the parent company of £500,000 was converted to equity and 500,000 Ordinary Shares of £1 each were issued.